Transperineal US-MRI Fusion-Guided Biopsy for the Detection of Clinical Significant Prostate Cancer: A Systematic Review and Meta-Analysis Comparing Cognitive and Software-Assisted Technique
Cancers · 30.06.2023 · 15 (13) · 3443
DOI: 10.3390/cancers15133443 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 30.06.2023. Verfasst von Giacomo Maria Pirola und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, San Giuseppe Hospital, IRCCS Multimedica, 20123 Milano, Italy. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
We aimed to find potential differences in clinically significant prostate cancer (csPCa) detection rates between transperineal software-assisted fusion biopsy (saFB) and cognitive fusion biopsies (cFB).
Methods
A systematic review of the literature was performed to identify comparative studies using PubMed, EMBASE, and Scopus according to the PICOS criteria. Cancer detection and complication rates were pooled using the Cochran–Mantel–Haenszel method with the random effect model and reported as odds ratios (ORs), 95% confidence intervals (CI), and p-values. A meta-analysis was performed using Review Manager (RevMan) 5.4 software by Cochrane Collaboration. The quality assessment of the included studies was performed using the Cochrane Risk of Bias tool, using RoB 2 for randomized studies and ROBINS-I for retrospective and nonrandomized ones.
Results
Eight studies were included for the meta-analysis, including 1149 cases in software-based and 963 cases in cognitive fusion biopsy. The detection rates of csPCa were similar between the two groups (OR 1.01, 95% CI 0.74–1.37, p = 0.95). Study heterogeneity was low (I2 55%).
Conclusion
There is no actual evidence of the superiority of saFB over cFB in terms of the csPCa detection rate. Operator experience and software availability can drive the choice of one fusion technique over the other.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, San Giuseppe Hospital, IRCCS Multimedica, 20123 Milano, Italy.
- Department of Urology, University Hospital "Ospedali Riuniti", Polytechnic University of Marche Region, 60131 Ancona, Italy.
- Urology Unit, Fondazione PTV Policlinico Tor Vergata University Hospital, 00133 Rome, Italy.
- Department of Urology, Usl Toscana Sud Est, San Donato Hospital, 52100 Arezzo, Italy.
- Department of Urology, A.O.U.I. Verona University, 37129 Verona, Italy.
- Maternal Infant and Urologic Sciences, Policlinico Umberto I Hospital, "Sapienza" University of Rome, 00185 Rome, Italy.
ORCID-Profile: Giacomo Maria Pirola, Daniele Castellani, Luca Orecchia, Carlo Giulioni, Marilena Gubbiotti, Martina Maggi, Jeremy Yuen-Chun Teoh, Vineet Gauhar
Zitieren
APA
Pirola, G. M., Castellani, D., Orecchia, L., Giulioni, C., Gubbiotti, M., Rubilotta, E., Maggi, M., Teoh, J. Y., Gauhar, V., & Naselli, A. (2023). Transperineal US-MRI Fusion-Guided Biopsy for the Detection of Clinical Significant Prostate Cancer: A Systematic Review and Meta-Analysis Comparing Cognitive and Software-Assisted Technique. Cancers, 15(13), 3443. https://doi.org/10.3390/cancers15133443
Vancouver
Pirola GM, Castellani D, Orecchia L, Giulioni C, Gubbiotti M, Rubilotta E, et al. Transperineal US-MRI Fusion-Guided Biopsy for the Detection of Clinical Significant Prostate Cancer: A Systematic Review and Meta-Analysis Comparing Cognitive and Software-Assisted Technique. Cancers. 2023;15(13):3443. doi:10.3390/cancers15133443
BibTeX
@article{Pirola2023,
author = {Pirola, Giacomo Maria and Castellani, Daniele and Orecchia, Luca and Giulioni, Carlo and Gubbiotti, Marilena and Rubilotta, Emanuele and Maggi, Martina and Teoh, Jeremy Yuen-Chun and Gauhar, Vineet and Naselli, Angelo},
title = {Transperineal US-MRI Fusion-Guided Biopsy for the Detection of Clinical Significant Prostate Cancer: A Systematic Review and Meta-Analysis Comparing Cognitive and Software-Assisted Technique},
journal = {Cancers},
year = {2023},
volume = {15},
number = {13},
pages = {3443},
doi = {10.3390/cancers15133443}
}
EUVIMED